| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2019-2022 |
| Base Year |
2023 |
| Forecast Period |
2024-2032 |
| Cerebral Angiography Market Size 2023 |
USD 41.23 million |
| Cerebral Angiography Market, CAGR |
8.46% |
| Cerebral Angiography Market Size 2032 |
USD 65.23 million |
Market Overview:
The cerebral angiography market is poised for significant growth, with a projected rise from USD 41.23 million in 2023 to USD 65.23 million by 2032. This translates to a compelling compound annual growth rate (CAGR) of 8.46% over the forecast period. This market overview delves into the key factors driving this growth, explores emerging trends, and identifies potential opportunities for stakeholders in the medical technology industry.
The cerebral angiography market is on a trajectory of significant expansion, driven by several key factors. One major driver is the rising prevalence of cerebrovascular diseases, such as stroke, aneurysms, and arteriovenous malformations (AVMs). As these conditions remain leading causes of disability and mortality globally, the demand for advanced diagnostic tools like cerebral angiography continues to escalate. Moreover, technological advancements in cerebral angiography are pivotal in fueling market growth. Innovations like minimally invasive techniques and enhanced imaging resolution are revolutionizing diagnostic capabilities, offering reduced patient discomfort and greater accuracy in visualizing cerebral blood flow.
Another driving force behind market growth is the increasing healthcare expenditure worldwide. With governments and private payers allocating more resources towards advanced medical technologies, cerebral angiography is gaining recognition as a valuable diagnostic and treatment tool for cerebrovascular diseases. This trend is particularly pronounced in developing economies, where healthcare infrastructure is rapidly evolving to meet the growing demand for advanced diagnostic services. Furthermore, the market is witnessing a surge in awareness and early diagnosis of cerebrovascular diseases, leading to improved treatment outcomes. As public awareness grows and early detection becomes more prevalent, cerebral angiography’s role in providing detailed anatomical information about the cerebral vasculature becomes increasingly vital.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Download Sample
Market Drivers:
Rising Prevalence of Cerebrovascular Diseases:
The increasing global prevalence of cerebrovascular diseases, including stroke, aneurysms, and arteriovenous malformations (AVMs), is a significant driver for the cerebral angiography market. For instance, Specifically, there were over 12.2 million new strokes each year, and globally, one in four people over age 25 will have a stroke in their lifetime2.
These conditions profoundly affect blood flow to the brain and require accurate diagnosis and evaluation for effective intervention. With factors such as the aging population and associated risk factors like hypertension, diabetes, and high cholesterol contributing to the surge in cerebrovascular diseases, there is a growing demand for cerebral angiography procedures to facilitate timely intervention and improve patient outcomes. In a study of 2,899 cerebral angiography procedures, there were 39 (1.3%) neurologic complications.
Technological Advancements and Improved Techniques:
Continuous advancements in cerebral angiography technology are reshaping the market landscape. Innovations such as minimally invasive techniques like microcatheter angiography, advanced imaging systems with enhanced resolution and reduced radiation exposure, and the integration of 3D imaging technologies are enhancing the accuracy and efficacy of cerebral angiography procedures. For instance, advancements in catheter technology and digital subtraction angiography (DSA) have decreased the invasiveness and enabled the procedure to become minimally invasive. These advancements not only improve diagnostic capabilities but also contribute to faster recovery times and enhanced patient comfort, making cerebral angiography an indispensable tool for diagnosis and treatment planning.
Growing Focus on Early Diagnosis and Treatment:
There is a growing global emphasis on the early diagnosis and treatment of cerebrovascular diseases to minimize long-term neurological complications. For instance, stroke is the leading cause of adult disability worldwide, and it is critical to recognize stroke early and treat it rapidly to prevent or minimize morbidity and mortality. Cerebral angiography plays a crucial role in this proactive approach by enabling physicians to detect and address potential issues before they lead to significant damage. Moreover, advancements in neurointervention techniques have seen significant progress. For example, the technical success rate of neurointerventional surgeries was reported to be 96%, and the clinical success rate was 100%2. These advancements allow for minimally invasive procedures to treat aneurysms, blockages, and other vascular abnormalities identified through cerebral angiography, further underscoring its importance in early intervention strategies.
Increasing Healthcare Expenditure and Reimbursement Policies:
The rise in global healthcare expenditure, coupled with favorable reimbursement policies for cerebral angiography procedures in certain regions, is driving market growth. Governments and insurance companies recognize the cost-effectiveness of early diagnosis and treatment for cerebrovascular diseases, leading to improved accessibility to cerebral angiography. As reimbursement policies evolve to encompass these procedures, the market is expected to witness expanded patient access, thereby driving further growth in the cerebral angiography market. For instance, a total of $41.005 million was reimbursed by Medicare in 2020 for diagnostic procedures including cerebral angiograms.
Market Trends:
Rising Demand for Minimally Invasive Procedures:
Patients are increasingly seeking minimally invasive procedures due to faster recovery times, reduced discomfort, and less risk of complications. Cerebral angiography offers a minimally invasive approach to diagnose and assess blood vessel abnormalities in the brain and neck, contributing to its growing demand. For instance, from 2003 to 2018, minimally invasive surgery representation increased in all studied procedures: cholecystectomy (88% to 94%), inguinal hernia repair (20% to 47%), appendectomy (38% to 93%), colectomy (8% to 43%), gastrectomy (43% to 84%), and Nissen (71% to 91%).
Technological Advancements in Angiography Systems:
Advancements in imaging technology are propelling the market forward. Newer angiography systems offer improved image resolution, faster acquisition times, and greater accuracy in visualizing blood vessels. This leads to more precise diagnoses and improved treatment planning for cerebrovascular conditions. For example, coronary CT angiography (CCTA) could use prospective or retrospective ECG gating to collect the optimal phase to reconstruct the images at any heart rate, displaying the main branches of the coronary artery in multiple directions and analyzing the diseased vessels.
Increasing Prevalence of Cerebrovascular Diseases:
The global incidence of cerebrovascular diseases, such as stroke and aneurysms, is on the rise due to factors like aging populations, unhealthy lifestyles, and rising diabetes rates. Cerebral angiography plays a vital role in diagnosing these conditions, allowing for early intervention and potentially better patient outcomes. This growing disease burden fuels the market for cerebral angiography procedures. For instance, prevalent cases of total cardiovascular diseases nearly doubled from 271 million in 1990 to 523 million in 2019, and the number of cardiovascular disease deaths steadily increased from 12.1 million in 1990, reaching 18.6 million in 2019.
Expanding Applications in Neurovascular Interventions:
Cerebral angiography is not only used for diagnosis but also plays a crucial role in various neurovascular interventions. These interventions include procedures like thrombectomy for stroke treatment and embolization for blocking abnormal blood flow. The expanding applications of cerebral angiography in these minimally invasive treatments contribute to market growth. For instance, in recent years, preliminary clinical research has been published demonstrating the safety and feasibility of the technology in cerebral angiography and intracranial intervention.
Market Restraints and Challenges:
- High Cost of Equipment and Procedures: Cerebral angiography systems are complex and expensive medical devices. The initial investment cost for hospitals and clinics is substantial, impacting their willingness to adopt this technology. Furthermore, the procedure itself incurs high costs due to factors like contrast material, specialized personnel, and operating room time. This can limit patient access, particularly in regions with limited healthcare budgets.
- Concerns Regarding Patient Safety: Cerebral angiography is an invasive procedure that carries inherent risks, including bleeding, stroke, and allergic reactions to the contrast dye. While advancements are being made to minimize these risks, the potential for complications can deter some healthcare providers from recommending this procedure and some patients from undergoing it.
- Shortage of Skilled Professionals: Cerebral angiography requires highly trained and experienced medical professionals, including neurologists, radiologists, and technicians. A shortage of these specialists can limit the number of procedures performed in certain regions, hindering the market’s growth.
- Competition from Alternative Diagnostic Techniques: The development of less invasive diagnostic tools like magnetic resonance angiography (MRA) poses a competitive challenge to cerebral angiography. While MRA often requires longer scan times and may not be suitable for all patients, it offers a non-invasive alternative for some situations.
- Stringent Regulatory Requirements: The regulatory landscape surrounding medical devices is complex and constantly evolving. Strict regulations governing the approval and use of cerebral angiography systems can lead to lengthy and expensive development processes for manufacturers, potentially slowing down market innovation and adoption.
Recent Developments:
- In January 2022, GE Healthcare, medical technology company launched Revolution 360 Cerebral Angiography System. The new system provides high-quality 3D rotational angiography with 50% dose reduction as compared to previous systems. This helped GE Healthcare to strengthen its portfolio of neurovascular solutions and gain market share in the growing cerebral angiography market.
Segmentation Analysis:
By Procedure Type:
- Fluoroscopy Angiography: This traditional method utilizes X-ray imaging to capture blood vessel visualizations.
- CT Angiography: This non-invasive technique combines X-rays with computerized tomography (CT) scans to create detailed 3D images of blood vessels.
- Magnetic Resonance Angiography (MRA): This non-invasive method utilizes strong magnetic fields and radio waves to create detailed images of blood vessels without X-rays.
Segmentations:
By Procedure Type:
- Fluoroscopy Angiography
- CT Angiography
- Magnetic Resonance Angiography (MRA)
By Technology:
- Magnetic Resonance Angiography
- Computed Tomography
- Ultrasound
- Nuclear Imaging
- X-ray
By End User:
- Hospitals
- Diagnostic Imaging Centers
- Others
By Region:
- North America
- Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Key player:
- Siemens Healthineers AG
- GE Healthcare
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Shimadzu Corporation
- Medtronic plc
- Stryker Corporation
- Terumo Corporation
- Boston Scientific Corporation
- AngioDynamics, Inc.
- Penumbra, Inc.
- MicroPort Scientific Corporation
- Cook Medical LLC
Regional Analysis:
North America is currently anticipated to be a dominant player in the cerebral angiography market, likely holding a substantial market share. This dominance can be attributed to several factors, including a well-established healthcare infrastructure, a high prevalence of cerebrovascular diseases, and favorable government policies regarding healthcare expenditure. Additionally, the presence of leading medical device manufacturers in the region further strengthens North America’s position in this market.
Europe is another promising region for the cerebral angiography market. Rising geriatric populations and increasing awareness of neurological conditions are expected to drive market growth here. Moreover, advancements in medical technology and growing investments in healthcare infrastructure are likely to contribute positively to the European market.
Asia Pacific represents a region with immense potential for future growth in the cerebral angiography market. Factors like rising disposable incomes, increasing urbanization, and a growing focus on improving healthcare infrastructure are expected to propel market expansion in this region. China, in particular, is expected to witness a significant rise in demand for cerebral angiography procedures, driven by its large and aging population.
Latin America and the Middle East and Africa are anticipated to experience moderate growth in the cerebral angiography market. However, limited access to advanced healthcare facilities and lower disposable incomes in some parts of these regions might pose challenges to market expansion. Nevertheless, growing government initiatives aimed at improving healthcare infrastructure and increasing awareness of neurological disorders present opportunities for future growth.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Future Outlook:
- Rising Incidence of Cerebrovascular Disorders: The increasing prevalence of stroke, aneurysms, and other cerebrovascular diseases will continue to propel demand for cerebral angiography as a crucial diagnostic tool.
- Technological Advancements: Advancements in imaging techniques, such as 3D rotational angiography and flat-panel detectors, will enhance accuracy, reduce procedure time, and improve patient outcomes, fostering wider adoption.
- Growing Geriatric Population: The burgeoning global geriatric population, more susceptible to cerebrovascular issues, will fuel the demand for cerebral angiography procedures.
- Minimally Invasive Focus: The rising preference for minimally invasive procedures, offering faster recovery times and reduced patient discomfort, will favor cerebral angiography over traditional surgical interventions.
- Integration of Artificial Intelligence: The incorporation of artificial intelligence (AI) for image analysis and interpretation will expedite diagnosis and improve accuracy, leading to better treatment decisions.
- Growing Healthcare Infrastructure: Expanding healthcare infrastructure, particularly in developing economies, will increase access to advanced diagnostic tools like cerebral angiography.
- Focus on Early Detection: Heightened awareness about the benefits of early detection of cerebrovascular diseases will drive the utilization of cerebral angiography for preventative measures.
- Reimbursement Policies: Favorable government reimbursement policies for cerebral angiography procedures are likely to stimulate market growth in specific regions.
- Regional Market Expansion: The Asia Pacific region is expected to witness the fastest growth due to factors like rising disposable income, increasing awareness, and an aging population.
- Competition and Innovation: The market will witness intensified competition among established players and new entrants, fostering continuous innovation in technology and product development.
